Custom pathway design, CRISPR-based editing, and analytical QC to support metabolic optimization in insect cell hosts.
Send us your target product, insect cell host line, and analytical requirements, and we return a scoping plan covering design, editing, screening, and reporting.
Target design, CRISPR-based editing, screening, and analytical reporting are organized as one engagement so your team sees a single plan from scoping through handoff.
We map your target product route onto the insect cell host, review the sequence and annotation data you can share, and shortlist the genes or steps worth modifying before laboratory work begins.
Knockout-focused editing is carried out in the insect cell host, followed by locus-specific screening, genotyping of candidates, and the analytical readouts agreed at project start.
Insect cell lines differ in growth behaviour, glycosylation patterns, and how readily they can be cloned, so those differences are accounted for when planning an editing and screening strategy.
Screening depth and analytical readouts are chosen together with your team, so the data generated answers the question your programme is asking rather than a generic panel.
Design records, editing summaries, genotype data, and analytical tables are compiled into milestone reports so internal teams can continue.
Handoff is organized as a checklist, so it is clear which items are transferred at each milestone and which are supplied only when they are part of the agreed scope.
Scope is defined case by case after consultation; the table below lists the parameters customers most often adjust when planning a pathway optimization programme.
| Parameter | Typical project scope |
|---|---|
| Host system | Insect cell lines and expression context are assessed per project, with Sf9-type hosts commonly used as the working system when they fit the target route. |
| Target pathway and genes | Genes and pathway steps are selected from your target-product route and confirmed during design review; the final list is fixed in the statement of work. |
| Edit modality | Knockout-based modification is the primary modality; precise edits such as targeted insertions are evaluated case by case against donor design and locus context. |
| Design inputs | Available sequence information, annotation, and prior expression or analytical data are reviewed during design; gaps are flagged before laboratory work starts. |
| Screening depth | The number of targets, candidate clones, and screening rounds is defined per project rather than fixed, and is documented in the agreed scope. |
| Analytical readouts | Readouts such as metabolite profiling, transcript-level checks, or protein-level measurements are selected with your team according to the question the programme needs to answer. |
| Multi-allelic and polyploid loci | Insect cell lines can carry multi-allelic or polyploid target loci, so cloning and genotyping strategies are planned to establish which alleles were modified in each clone. |
| Off-target assessment | In silico prediction is performed against available genome information, and targeted amplicon checks can be added when they are part of the agreed scope. |
| Controls and references | Parent and untreated controls used for screening and analytical comparisons are defined during scoping and listed in the statement of work. |
| Technical support | Named scientific contact at project start; milestone review calls; email response within 1 business day |
Five stages take the project from scoping to reporting, and each stage has defined inputs, outputs, and review points before the next one begins.
We review your target product, insect cell host, pathway of interest, and analytical requirements, then agree on the genes in scope, the editing approach, and acceptance criteria in the statement of work.
Guide RNA and target-gene designs are prepared against the sequence and annotation available for the host line, with donor or construct requirements defined only when the project calls for a precise edit.
Editing reagents are introduced into the insect cell host, and treated cultures are progressed to recovery and cloning or pool-based selection according to the screening strategy agreed during scoping.
Candidate clones are screened with locus-specific assays, and genotypes are confirmed at the target locus with sequencing-based checks before any clone is advanced to analytical characterization.
Selected clones are profiled with the readouts agreed at project start, and results are compiled into a milestone report with datasets, genotype summaries, and supporting documentation.
The service is used where a target product route in an insect cell host needs host-side changes and measurable analytical follow-up.
When a recombinant protein route is limited by host-side pathway behaviour, we work on the genes and steps that shape that route, keeping the product construct itself outside the scope unless it is explicitly included.
For metabolite or intermediate targets, edits are planned to reduce competing routes and to adjust the steps feeding the target compound, with readouts selected to show whether the intended direction was reached in the clones delivered.
Where a programme needs to understand why a clone behaves as it does, selected clones are profiled with the agreed analytical readouts and the data is reported together with the genotype status of each clone.
Common points on scope, editing options, host handling, quality checks, and what is transferred at the end of a project.
We begin with a scoping discussion covering your target product, insect cell host, available sequence or annotation data, and the analytical readouts you need. From there we agree on the genes or pathway steps in scope, the editing approach, screening depth, and acceptance criteria, and those decisions are written into the statement of work before laboratory work begins.
Knockout-based modification is the primary edit modality and is the usual starting point for removing competing routes or redirecting a pathway. Precise edits such as targeted insertions are evaluated case by case, because feasibility depends on donor design, locus context, and the screening strategy available for your host line. If a precise edit is not a practical route for your target, we say so during scoping.
Insect cell lines can carry more than two copies of a target locus, so a single editing event may not alter every functional allele. We plan cloning and genotyping accordingly, using locus-specific assays and sequencing-based checks to establish which alleles were modified in each candidate clone, and we report genotype status rather than assuming complete alteration.
Candidate clones are screened with locus-specific assays before characterization, and reported genotypes are confirmed by sequencing at the target locus. Off-target work begins with in silico prediction against available genome information, and targeted amplicon checks can be added when they are part of the agreed scope. Analytical readouts are run with the controls defined in the statement of work.
Readouts such as metabolite profiles or expression-level checks describe the state of the clones delivered; they are not a guarantee that a production target will be met, since outcomes depend on target biology and process context. If results fall outside the expected direction, we review the design, screening data, and assay conditions with you and outline follow-on options, which would be scoped as a separate phase.
Duration depends on the host line, the number of targets, the edit type, and the screening depth agreed for the programme. Because those parameters vary widely between projects, the milestone schedule is set in the statement of work rather than published as a fixed figure, and any change in scope is discussed at the next milestone review.
Get a customized quote for your Insect Cells Metabolic Pathway Optimization Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.